<body><a name="drugname"></a><table class="topbox" width="100%">
<tr>
<td><span class="topboxgenname">MODAFINIL </span><br/>(mod-a'fi-nil)<br/><span class="topboxtradename">Provigil, </span><span class="topboxtradename">Alertec <img border="0" src="../images/maple.gif"/><br/></span><b>Classifications:</b> <span class="classification">central nervous system (cns) agent</span>; <span class="classification">cerebral stimulant, miscellaneous</span><br/><b>Pregnancy Category: </b>C<br/><b>Controlled Substance: </b>Schedule IV<br/></td>
</tr>
</table>
<h1><a name="avail">Availability</a></h1>
<p>100 mg, 200 mg capsules</p>
<h1><a name="action">Actions</a></h1>
<p>CNS stimulant; the precise mechanism of action is unknown. Modafinil causes an increase in extracellular dopamine.</p>
<h1><a name="therapef">Therapeutic Effects</a></h1>
<p>Modafinil causes wakefulness, increased locomotor activity, and psychoactive and euphoric effects.</p>
<h1><a name="uses">Uses</a></h1>
<p>Improve wakefulness in patients with narcolepsy or excessive sleepiness associated with shift work sleep disorder, obstructive
         sleep apnea/hypnea syndrome.
      </p>
<h1><a name="unlabeleduses">Unlabeled Uses</a></h1>
<p>Fatigue related to organic brain syndrome or multiple sclerosis.</p>
<h1><a name="contrain">Contraindications</a></h1>
<p>Hypersensitivity to modafinil; acute MI, valvular heart disease; pregnancy (category C); lactation. Safety and efficacy in
         children 
      </p><h1><a name="precaution">Cautious Use</a></h1>
<p>Cardiovascular disease including left ventricular hypertrophy; cardiac disease, ischemic ECG changes, chest pain, arrhythmias,
         mitral valve prolapse, recent MI, unstable angina; older adults; history of drug or alcohol abuse; psychosis or emotional
         instability; leukopenia, MI, neurological disease, hypertension, severe hepatic disease, severe renal impairment, renal failure,
         seizure disorder, sleep apnea.
      </p>
<h1><a name="rtedsg">Route &amp; Dosage</a></h1>
<table cellpadding="4" cellspacing="0" class="rdbox" width="100%">
<tr>
<td><span class="indicationtitle">Narcolepsy, Fatigue</span><br/><span class="rdage">Adult:</span> <span class="rdroute">PO</span> 200 mg/d as single dose in the morning<br/><br/><span class="impairmenttitle">Hepatic Impairment</span><br/>Reduce dose by 50%<br/><br/></td>
</tr>
</table>
<h1><a name="admintn">Administration</a></h1><span class="adminroutetype">Oral</span><br/><ul>
<li>Give in the morning shortly after awakening.</li>
<li>Store at 15°30° C (59°86° F).</li>
</ul>
<h1><a name="adverse">Adverse Effects (<img src="../images/special/greaterorequal.gif"/>1%)</a></h1><span class="typehead">Body as a Whole:</span> Chest pain, neck pain, chills, eosinophilia. <span class="typehead">CNS:</span>
<span class="speceff-common">Headache,</span> nervousness, dizziness, depression, anxiety, cataplexy, insomnia, paresthesia, dyskinesia, hypertonia. <span class="typehead">CV:</span> Hypotension, hypertension, vasodilation, arrhythmia, syncope. <span class="typehead">GI:</span>
<span class="speceff-common">Nausea,</span> diarrhea, dry mouth, anorexia, abnormal LFTs, vomiting, mouth ulcer, gingivitis, thirst. <span class="typehead">Respiratory:</span> Rhinitis, pharyngitis, lung disorder, dyspnea. <span class="typehead">Skin:</span> Dry skin. <span class="typehead">Special Senses:</span> Amblyopia, abnormal vision. 
      <h1><a name="interactions">Interactions</a></h1><span class="typehead">Drug:</span>
<b>Methylphenidate</b> may delay absorption of <b>modafinil;</b>
<b>modafinil</b> may decrease levels of <b>cyclosporine,</b>
<span class="classification">oral contraceptives</span>; <b>modafinil</b> may increase levels of <b>clomipramine,</b>
<b>phenytoin,</b>
<b>warfarin,</b>
<span class="classification">tricyclic antidepressants</span>. 
      <h1><a name="pharmaks">Pharmacokinetics</a></h1><span class="typehead">Absorption:</span> Rapidly absorbed. <span class="typehead">Peak:</span> 24 h. <span class="typehead">Distribution:</span> Approximately 60% protein bound. <span class="typehead">Metabolism:</span>  Metabolized in liver to inactive metabolites. <span class="typehead">Elimination:</span> Excreted in urine. <span class="typehead">Half-Life:</span> 15 h. 
      <h1><a name="nursing"><span class="implictitle">Nursing Implications</span></a></h1>
<p><span class="adeffecttitle">Assessment &amp; Drug Effects</span></p>
<ul>
<li>Therapeutic effectiveness: Indicated by improved daytime wakefulness.</li>
<li>Monitor BP and cardiovascular status, especially with preexisting hypertension and mitral valve prolapse or other CV condition.</li>
<li>Monitor for S&amp;S of psychosis, especially when history of psychotic episodes exists.</li>
<li>Lab tests: Periodic liver function tests.</li>
<li>Coadministered drugs: Monitor INR with warfarin for first several months and when dosage is changed; monitor for toxicity
            with phenytoin.
         </li>
</ul>
<p><span class="eductitle">Patient &amp; Family Education</span></p>
<ul>
<li>Use barrier contraceptive instead of/in addition to hormonal contraceptive.</li>
<li>Inform physician of all prescription or OTC drugs in/added to your regimen.</li>
<li>Notify physician if any S&amp;S of an allergic reaction appear.</li>
<li>Do not breast feed while taking this drug without consulting physician.</li>
</ul>
<hr/>
<p><span class="footer">Common adverse effects in <i>italic</i>, life-threatening effects <u>underlined</u>; generic names in <b>bold</b>; classifications in <small>SMALL CAPS</small>; <img border="0" src="../images/maple.gif"/> Canadian drug name; <img border="0" src="../images/pr.gif"/> Prototype drug</span></p>
</body>